TW200640921A - Crystalline form of an indazole-carboxamide compound - Google Patents

Crystalline form of an indazole-carboxamide compound

Info

Publication number
TW200640921A
TW200640921A TW095105173A TW95105173A TW200640921A TW 200640921 A TW200640921 A TW 200640921A TW 095105173 A TW095105173 A TW 095105173A TW 95105173 A TW95105173 A TW 95105173A TW 200640921 A TW200640921 A TW 200640921A
Authority
TW
Taiwan
Prior art keywords
indazole
salts
crystalline form
carboxamide compound
crystalline
Prior art date
Application number
TW095105173A
Other languages
English (en)
Chinese (zh)
Inventor
Paul R Fatheree
S D Turner
Robert S Chao
Jyan-Wei Liu
Hao Zhang
Junning Lee
Daniel Genov
Original Assignee
Theravance Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theravance Inc filed Critical Theravance Inc
Publication of TW200640921A publication Critical patent/TW200640921A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
TW095105173A 2005-02-17 2006-02-16 Crystalline form of an indazole-carboxamide compound TW200640921A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65367705P 2005-02-17 2005-02-17

Publications (1)

Publication Number Publication Date
TW200640921A true TW200640921A (en) 2006-12-01

Family

ID=36424659

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095105173A TW200640921A (en) 2005-02-17 2006-02-16 Crystalline form of an indazole-carboxamide compound

Country Status (5)

Country Link
US (1) US20060183901A1 (enExample)
EP (1) EP1848716A1 (enExample)
JP (1) JP2008530225A (enExample)
TW (1) TW200640921A (enExample)
WO (1) WO2006088988A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI377206B (en) 2005-04-06 2012-11-21 Theravance Inc Crystalline form of a quinolinone-carboxamide compound
GB0525068D0 (en) 2005-12-08 2006-01-18 Novartis Ag Organic compounds
EP1984362B1 (en) * 2006-02-16 2011-05-11 Theravance, Inc. Process for preparing intermediates to 5-ht4 receptor agonist compounds
KR20110050683A (ko) * 2008-08-19 2011-05-16 시노팜 타이완 리미티드 그라니세트론 염산염의 다형 형태 및 이의 제조 방법
US8349852B2 (en) 2009-01-13 2013-01-08 Novartis Ag Quinazolinone derivatives useful as vanilloid antagonists
AR080056A1 (es) 2010-02-01 2012-03-07 Novartis Ag Derivados de ciclohexil-amida como antagonistas de los receptores de crf
CN102762572A (zh) 2010-02-01 2012-10-31 诺瓦提斯公司 作为CRF-1受体拮抗剂的吡唑并[5,1b]*唑衍生物
US8835444B2 (en) 2010-02-02 2014-09-16 Novartis Ag Cyclohexyl amide derivatives as CRF receptor antagonists

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4937247A (en) * 1985-04-27 1990-06-26 Beecham Group P.L.C. 1-acyl indazoles
IT1226389B (it) * 1988-07-12 1991-01-15 Angeli Inst Spa Nuovi derivati ammidinici e guanidinici
JP3829879B2 (ja) * 1994-05-18 2006-10-04 大正製薬株式会社 キノリンカルボン酸誘導体
US5654320A (en) * 1995-03-16 1997-08-05 Eli Lilly And Company Indazolecarboxamides
IT1291569B1 (it) * 1997-04-15 1999-01-11 Angelini Ricerche Spa Indazolammidi come agenti serotoninergici
US6069152A (en) * 1997-10-07 2000-05-30 Eli Lilly And Company 5-HT4 agonists and antagonists
TW200533348A (en) * 2004-02-18 2005-10-16 Theravance Inc Indazole-carboxamide compounds as 5-ht4 receptor agonists
DE602005021696D1 (de) * 2004-12-22 2010-07-15 Theravance Inc Indazolcarbonsäureamidverbindungen

Also Published As

Publication number Publication date
WO2006088988A1 (en) 2006-08-24
US20060183901A1 (en) 2006-08-17
EP1848716A1 (en) 2007-10-31
JP2008530225A (ja) 2008-08-07

Similar Documents

Publication Publication Date Title
TW200643020A (en) Crystalline form of a quinolinone-carboxamide compound
MY139296A (en) CRYSTALLINE ß2 ADRENERGIC RECEPTOR AGONIST
MXPA05012678A (es) Forma cristalina del agonista del receptor adrenergico beta2.
MA29088B1 (fr) Composes d&#39;indazole-carboxamide.
AP1822A (en) Substituted pyridinones as modulators of P38 MAP kinase.
IL184898A0 (en) Pyrrolopyrimidine derivatives and pharmaceutical compositions containing the same
TW200800981A (en) 8-azabicyclo[3.2.1]octane compounds as MU opioid receptor antagonists
EA200970500A1 (ru) СОЕДИНЕНИЯ ТЕТРАГИДРОЦИКЛОПЕНТА[b]ИНДОЛА В КАЧЕСТВЕ МОДУЛЯТОРОВ РЕЦЕПТОРА АНДРОГЕНОВ
MY155036A (en) Quinolinone-carboxamide compounds as 5-ht4 receptor agonists
MX2010002171A (es) Compuestos 8-azabiciclo[3.2.1] octil-2 hidroxibenzamida como antagonistas de los receptores opioides mu.
TN2012000132A1 (en) N-((1r,2s,5r)-5-(tert-butylamino)-2-((s)-3-(7-tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a dual modulator of chemokine receptor activity, crystalline forms and processes
MX2009009141A (es) Formas cristalinas de un compuesto de 8-azabiciclo[3,2,1]octano.
BR0308592A (pt) Derivados de piperidina ou 8-azabiciclo [3.2.1] oct-3-il-piperidina, de utilidade como moduladores da atividade do receptor de quimocina (especialmente ccr5)
WO2006052889A3 (en) Quinolinone-carboxamide compounds
TW200640921A (en) Crystalline form of an indazole-carboxamide compound
NO20090190L (no) Modulatorer av kjemokin reseptor aktivitet, krystallinske former og fremgangsmate
MY147756A (en) Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists
NO20080671L (no) Bisykliske piperaziner som metabotrofiske glutamatreseptorantagonister
PL1853232T3 (pl) Trwałe postaci krystaliczne mesylanu bifeprunoksu, postaci dawkowania oraz sposoby ich stosowania
MY179041A (en) Crystalline forms of a 3-carboxypropyl-aminotetralin compound
TW200740428A (en) Substituted propanamide derivatives and pharmaceutical compositions thereof
UA81405C2 (en) Substituted pyridinones as modulators of p38 map kinase
MY143574A (en) Carbamate compounds as 5-ht4 receptor agonists
UA103026C2 (ru) Соединение с серотонинергической активностью, способ его получения и фармацевтическая композиция, которая его содержит
FR2884824B1 (fr) Derives de 1h-pyrimido[4,5-b]indole, leur preparation et leur application en therapeutique